Regional differences in clinical presentation and prognosis of patients with post-sustained virologic response (SVR) hepatocellular carcinoma
Hidenori Toyoda,Mounika Kanneganti,Jonathan Melendez-Torres,Neehar D Parikh,Prasun K Jalal,Federico Piñero,Manuel Mendizabal,Ezequiel Ridruejo,Hugo Cheinquer,Andrea Casadei-Gardini,Arndt Weinmann,Markus Peck-Radosavljevic,Jean-Francois Dufour,Pompilia Radu,Gamal Shiha,Riham Soliman,Shiv K Sarin,Manoj Kumar,Jing-Houng Wang,Pisit Tangkijvanich,Wattana Sukeepaisarnjaroen,Masanori Atsukawa,Haruki Uojima,Akito Nozaki,Makoto Nakamuta,Koichi Takaguchi,Atsushi Hiraoka,Hiroshi Abe,Kentaro Matsuura,Tsunamasa Watanabe,Noritomo Shimada,Kunihiko Tsuji,Toru Ishikawa,Shigeru Mikami,Ei Itobayashi,Amit G Singal,Philip J Johnson,Neehar D. Parikh,Prasun K. Jalal,Shiv K. Sarin,Amit G. Singal,Philip J. Johnson
DOI: https://doi.org/10.1016/j.cgh.2023.06.026
IF: 13.576
2023-07-12
Clinical Gastroenterology and Hepatology
Abstract:Background & Amis : Widespread use of direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection has resulted in increased numbers of patients with hepatocellular carcinoma (HCC) after achieving sustained virologic response ('post-SVR HCC') worldwide. Few data compare regional differences in presentation and prognosis of patients with post-SVR HCC. Methods We identified patients with advanced fibrosis (F3/F4) who developed incident post-SVR HCC between March, 2015 and October, 2021 from 30 sites in Europe, North America, South America, Middle East, South Asia, East Asia, and Southeast Asia. We compared patient demographics, liver dysfunction, and tumor burden by region. We compared overall survival by region using Kaplan-Meier analysis and identified factors associated with survival using multivariable Cox regression analysis. Results Among 8,796 patients with advanced fibrosis or cirrhosis who achieved SVR, 583 (6.6%) developed incident HCC. There was marked regional variation in the proportion of detection by surveillance (range: 59.5–100%), median maximum tumor diameter (range: 1.8–5.0 cm), and proportion with multinodular HCC (range: 15.4–60.8%). Prognosis of patients highly varied by region (HR range: 1.82–9.92), with the highest survival in East Asia, North America, and South America, and lowest in the Middle East and South Asia. After adjusting for geographic region, HCC surveillance was associated with early-stage detection (BCLC stage 0/A: 71.0% vs. 21.3%, p<0.0001) and lower mortality (adjusted HR 0.29, 95%CI 0.18–0.46). Conclusions Clinical characteristics, including early-stage detection, and prognosis of post-SVR HCC significantly differed across geographic regions. Surveillance utilization appears to be a high-yield intervention target to improve prognosis among patients with post-SVR HCC globally.
gastroenterology & hepatology